foto
VIEW OUR WEB SEMINARS
LATEST NEWS

OctoPlus publishes prospectus for listing of shares issued on 18 December 2009



HALF-YEAR RESULTS: 6 AUGUST

Click here to go to the webcast of OctoPlus' half-year results on Thursday 6 August at 10 AM CET



ANNUAL REPORT 2008

Click here to directly access OctoPlus' Annual Report 2008



GMP EXPANSION

OctoPlus has increased its fill & finish capacity by expanding its GMP facility



OCTO SHARE PRICE
HOME dashNL dash CONTACT

 

FORMULATION DEVELOPMENT

OctoPlus offers special formulation and manufacturing expertise in the following areas:

Our partners turn to OctoPlus for tailor-made pharmaceutical development, specialized expertise on formulation and for difficult-to-formulate compounds and extraordinary formulations.

For more information about our formulation development and clinical manufacturing services, please refer to our in-depth technical factsheets.